Targeted attack: new method aims to starve and poison bone tumors
NCT ID NCT06562673
Summary
This study tested a new way to deliver cancer drugs directly to bone tumors (osteosarcoma) before surgery. Researchers gave a two-drug combination through a tiny tube placed in an artery feeding the tumor, along with standard chemotherapy given through a vein. The goal was to see if this targeted approach was safe and could kill more of the tumor than traditional methods.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital,
Shanghai, 200233, China
Conditions
Explore the condition pages connected to this study.